Catabasis Pharmaceuticals' IPO

Catabasis Pharmaceuticals raised a round of funding on June 25, 2015. Investors include Public.

Catabasis is a clinical stage biotechnology company with a robust portfolio of investigational new medicines for the treatment of cardiovascular, metabolic and inflammatory diseases. The company's dru…

Articles about Catabasis Pharmaceuticals' IPO: